DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs
The Drugs Technical Advisory Board (DTAB) has directed the Central drug regulator to take up the matter related to withdrawal of product license for antibiotic fixed dose combinations (FDCs), which…